Pharma contract manufacturing sees historic surge amidst inflation and investment challenges: GlobalData Read more
Inflation, declining FDA drug approvals will pose challenges for pharma CMOs in 2023: GlobalData Read more
CMOs will account for four of five top bio-manufacturing capacities in 2025: CPhI Worldwide Report Read more